Home › Oropharyngeal Cancer › Iowa › Des Moines
Oropharyngeal Cancer clinical trials in Des Moines, IA
3 studies for Oropharyngeal Cancer are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Broadlawns Medical Center, Des Moines
- and 5 more
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines
- and 4 more
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Iowa Methodist Medical Center, Des Moines
- UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
- Mercy Medical Center - Des Moines, Des Moines
- and 4 more
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Tampa, FL5 studies
- Kansas City, MO5 studies
- Pittsburgh, PA5 studies
- Philadelphia, PA5 studies
- Los Angeles, CA5 studies
- Milwaukee, WI5 studies
Other studies in Des Moines
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer8 studies
- Colorectal Cancer8 studies
- Chronic Lymphocytic Leukemia8 studies
- Bladder Cancer6 studies
- Overweight6 studies
- Multiple Myeloma5 studies
- Obesity5 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
- Cardiovascular Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.